The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How have key drivers contributed to the rapid growth of the neuroendovascular coil market?
The growing prevalence of neurovascular diseases is expected to propel the growth of the neuroendovascular coil market going forward. Neurovascular diseases affect the blood vessels supplying the nervous system, often leading to neurological symptoms and complications. Neuroendovascular coils are used in treating neurovascular diseases by being inserted into blood vessels to block off or stabilize abnormal blood vessel structures, reducing the risk of bleeding or other complications. For instance, in November 2023, according to a report published by the National Board of Health and Welfare (Socialstyrelsen), a Sweden-based government agency, in 2022, around 26,800 strokes were reported, impacting approximately 25,100 individuals. Among those who experienced a stroke that year, 12 percent died on the same day, 23 percent within 28 days, and 34 percent within one year. Therefore, the growing prevalence of neurovascular diseases is driving the growth of the neuroendovascular coil market.
Neuroendovascular Coil Market Driver: Surge In Healthcare Expenditure Fuels Neuroendovascular Coil Market Growth
The growing healthcare expenditure is expected to propel the growth of the neuroendovascular coil market going forward. Healthcare expenditure refers to the amount of money spent on healthcare services, including medical goods and services, public health activities, and administration. Growing healthcare expenditure is driven by factors such as an aging population, advancements in medical technology, rising costs of pharmaceuticals, and increased prevalence of chronic diseases. The escalating healthcare expenditure contributes to advancements in neuroendovascular coil technology, fostering innovation, and accessibility, and improving patient outcomes in the treatment of cerebral aneurysms and vascular disorders. For instance, in June 2024, according to Health Affairs, a US-based academic journal, the national healthcare expenditure in the U.S. is expected to rise from $4,799.3 billion in 2023 to $5,048.8 billion in 2024, indicating an increase of about $249.5 billion. Therefore, the rise in healthcare expenditures is driving the growth of the neuroendovascular coil market.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13495&type=smp
How has the neuroendovascular coil market size evolved, and what are the latest forecasts for its expansion?
The neuroendovascular coil market size has grown strongly in recent years. It will grow from $1.29 billion in 2024 to $1.4 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing incidence of neurovascular diseases, growing aging population, improved diagnostic technologies, expansion of neurointerventional facilities, awareness and education initiatives, regulatory approvals and standards.
The neuroendovascular coil market size is expected to see strong growth in the next few years. It will grow to $1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to continuous rise in neurovascular cases, expansion of neurointerventional services, focus on early intervention, global healthcare infrastructure growth, patient-centric care trends, international collaborations in research. Major trends in the forecast period include advancements in detachable neuroendovascular coils, rise in utilization of liquid embolics, development of bioactive and bioabsorbable coils, integration of dual-layer coil technologies, focus on flow diverters for aneurysm treatment.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13495&type=smp
Which major companies dominate the neuroendovascular coil market?
Major companies operating in the neuroendovascular coil market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Kaneka Neurovascular USA, W.L. Gore & Associates Inc., Cook Group Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., MicroVention Inc., Medikit Co. Ltd., Minnetronix Medical Inc., SurModics Inc., Galen Medical Group P.C, Balt USA LLC, Acandis GmbH, Rapid Medical Ltd., Allium Medical Solutions Ltd., Shape Memory Medical Inc., InnoCore Pharmaceuticals BV, Wuhan HNC Technology Co. Ltd., Neural Co. Ltd., Three Rivers Medical Inc.
What trends will shape the future of the neuralgia treatment market?
Major companies operating in the neuroendovascular coil market are focused on developing soft and unique-shaped coils to gain a competitive edge in the market. In neuroendovascular procedures, soft and unique shapes, such as tetrahedral coils, enhance aneurysm treatment by conforming to vessel anatomy, reducing complications, and improving patient outcomes, especially in complex cases. For instance, in December 2022, Stryker Corporation, a US-based medical technology company that manufactures neuroendovascular coils, launched the Target Tetra Detachable Coil, which combines a new tetrahedral shape and softness level and is specifically designed to treat small aneurysms. It provides a 2-in-1 feature with a unique tetrahedral shape that allows stability in wide-necked aneurysms and a soft helical tail. This shape offers strong memory and is soft at the same time, making it a good choice for treating small aneurysms.
Which region dominates the neuroendovascular coil market, and what factors contribute to its leadership?
North America was the largest region in the neuroendovascular coil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroendovascular coil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/neuroendovascular-coil-global-market-report
How is the neuroendovascular coil market segmented, and which segment holds the largest share?
The neuroendovascular coil market covered in this report is segmented –
1) By Product Type: Guglielmi Detachable Coils (GDCs), Matrix Coils
2) By Indication: Ruptured Aneurysm, Unruptured Aneurysm
3) By Application: Tumor Surgery, Medical Teaching
4) By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Stroke Centers, Other End Users
Subsegments:
1) By Guglielmi Detachable Coils (GDCs): Soft GDCs, Standard GDCs, Detachable GDCs With Various Configurations
2) By Matrix Coils: Soft Matrix Coils, Coated Matrix Coils, Detachable Matrix Coils, Flow Diverter Matrix Coils
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13495
What defines the structure and scope of the neuroendovascular coil market?
A neuroendovascular coil is a thin wire inserted into blood vessels to block off or divert blood flow from the affected area, promoting clotting and preventing further complications. It is a medical device for treating cerebral aneurysms and other vascular abnormalities.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
